Siddharth Patel, MD, graduated summa cum laude in Electrical Engineering from the University of Texas at Dallas and earned his medical degree from the University of Texas Southwestern Medical School. He then completed his internal medicine residency at the Brigham and Women’s Hospital, where he is currently a senior fellow in cardiovascular medicine and critical care as well as a research fellow with the TIMI Study Group. Dr. Patel’s clinical interests include heart failure, cardiogenic shock and critical care cardiology. His research is focused on the application of biomarkers and genetics to identify high-risk patients and better inform clinical decision making.
Filipe Moura, MD, PhD, earned his medical degree from the University of Brasilia, Brazil. He then received his PhD degree from the State University of Campinas, where he worked on translational research that focused on insulin sensitivity in patients with acute myocardial infarction. He then completed his internship and residency in internal medicine at New York-Presbyterian Hospital/Weill Cornell Medical Center. He is currently a senior cardiology fellow at Brigham and Women’s Hospital and a research fellow at the TIMI Study Group. He is interested in clinical trials involving cardiometabolic health, and his research is focused on using both clinical data and genetics to characterize sub-phenotypes of obesity and their relevance to atherothrombotic and heart failure risk profiling.
André Zimerman, MD, PhD, received his medical degree from the Federal University of Rio Grande do Sul (Brazil) and completed his internal medicine residency and cardiology fellowship at the Hospital de Clinicas de Porto Alegre. He then received his PhD degree from the Federal University of Rio Grande do Sul, for research on the limitations of functional class assessment in mild heart failure. His clinical interests are centered around preventive cardiology, namely lipidology and cardiometabolic health. In addition to his clinical interests, his research interests also include applied behavioral science and innovative statistical methods in cardiovascular research.
Prakriti Gaba, MD, graduated with high honors from the California Institute of Technology, where she double majored in bioengineering and business economics. She earned her medical degree from the Mayo Clinic Alix School of Medicine and completed internal medicine training at Columbia University Medical Center in New York City. She is currently a senior cardiology fellow at the Brigham and Women’s Hospital/Harvard Medical School, where she is also a research fellow at the TIMI Study Group and an MPH degree candidate at the Harvard School of Public Health. She is passionate about pursuing a clinical career in Interventional Cardiology, and her research interests involve investigating novel treatments for coronary artery disease as well as rethinking clinical trial design.
Samer Al Said, MD, MSc, obtained his medical degree from Damascus University in Syria, with clinical electives at Oxford Medical School and the University of Leicester in England. He later pursued a Master of Science degree in Translational Medical Research at Heidelberg University in Germany. Additionally, he completed his Doctorate in the lab of experimental Heart Surgery at Heidelberg University.
Subsequently, he underwent clinical training in cardiology at the University Hospitals in Freiburg and Heidelberg in Germany. Following this, he pursued a Fellowship in Vascular Medicine and Endovascular Intervention at the University Heart Center Bad Krozingen. Currently, his research primarily focuses on antithrombotic therapy, with a special interest in evidence-based medicine. He has actively contributed to several Cochrane Reviews, and his work has been recognized with two UK National Institute for Health Research (NIHR) Cochrane Incentive Funding Awards.
Yu Mi Kang, MD, PhD, received a B.Sc. in Integrative Biology from the University of Toronto, Canada, and an MD-Master of Science with high honors from Chonbuk National University, South Korea. She completed clinical training in internal medicine and endocrinology, and a doctorate at the University of Ulsan/Asan Medical Center, Seoul, Korea. Dr. Kang studied the role of various biomarkers and adipokines in endothelial dysfunction for her PhD and led national-level epidemiologic studies on cardiometabolic risk-obesity profiling. She completed her US medical credentialing at Yale University/Bridgeport Hospital and is currently an endocrinology fellow at Brigham and Women’s Hospital and a research fellow in the TIMI Study Group. Dr. Kang’s research focuses on the clinical trials of pharmacologic agents targeting high-risk conditions such as obesity, type 2 diabetes, and dyslipidemia, with a particular interest in pharmacoepidemiologic evidences of maximizing cardiometabolic benefits through individualized approaches based on comprehensive risk stratification.
Paul Haller, MD, PhD grew up in Austria and graduated from the Medical University of Vienna. Before becoming a resident and fellow in internal medicine and cardiology at the University Heart and Vascular Center Hamburg, he worked for 2.5 years as a full-time researcher focusing on experimental biomarkers and ischemia/reperfusion injury in patients with acute myocardial infarction. He received his doctorate in Medicine (Dr. med.) from the Medical Faculty of the University of Hamburg, Germany, and his PhD from the Medical University of Vienna, Austria. Dr. Haller’s clinical focus is on acute myocardial infarction, heart failure and valvular heart disease. His research interests focus on biomarker research for diagnostic and prognostic purposes, including cardiovascular risk assessment in the context of primary and secondary prevention, and extend further to cardiovascular clinical trials, heart failure, and antithrombotic management.